Literature DB >> 35771868

Complement component 3 haplotypes influence serum complement activity and milk production traits in Chinese Holstein cattle.

Yonghui Wang1, Junyu Zhai1, Chunhong Yang2, Jingpeng Wang2, Yan Sun1, Yuhua Li1, Zhihua Ju2, Jingming Huang2, Changfa Wang1.   

Abstract

Complement component 3 (C3) is the key molecule of the three pathways of complement activation (alternative, classical, and lectin pathways), which are involved in phagocytosis, inflammation, and immunoregulation processes to destroy infectious microorganisms. In this study, three novel single-nucleotide polymorphisms (SNPs) (g.-1293C>G located in the 5'-flanking region, g.56T>C in exon I, and g.7017C>T in exon XII) of the C3 gene were detected using created restriction site polymerase chain reaction, restriction fragment length polymorphism, and DNA sequencing in 952 cattle from three Chinese breeds. The genotypes and haplotypes were analyzed to investigate the polymorphisms and their possible implications, with particular investigative focus on their associations with serum C3 level, complement hemolytic activity (CH50 and ACH50), and milk production traits. The g.56T>C SNP in exon I affected the serum ACH50 (P<0.01) and the milk somatic cell score (SCS) (P<0.05), and the g.7017C>T SNP in exon XII significantly affected the serum ACH50 values (P<0.01). Moreover, statistical analyses revealed that individuals with genotypic combination CCC/GCC showed significantly lower SCS and the lowest C3 concentration in serum compared with cows with CCC/GTT (P = 0.0007) and CTT/CTT (P = 0.0021); the individuals with CCC/CCT had significantly higher ACH50 values than those with CCC/CTC (P = 0.0008) and CTC/GTC (P = 0.001); cows with CCT/CTT had higher values of CH50 and 305-day milk yield (P>0.05). The C3 expression levels were significantly increased in lung and mammary tissues (P<0.05), while significantly decreased in heart, spleen, liver, and kidney tissues in mastitis cows compared with those in healthy animals (P<0.01), respectively. Bacterial counts of serum antibacterial activities were also completed to verify the effect of SNPs on resistance to mastitis pathogens. Genetically resistant cows (CCC/GCC) had serum with noticeably higher antibacterial activity against S. aureus and E. coli in vitro than the genetically susceptible CCC/GTT cows (P<0.05). Results from this study imply that the C3 gene plays a role in resistance to bacterial infection and that it can be used as a molecular marker for complement activity and traits related to milk production.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35771868      PMCID: PMC9246146          DOI: 10.1371/journal.pone.0268959

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Introduction

Mastitis, an inflammatory disease of the mammary gland that is generally caused by intramammary infections, is the most frequent, complex, and costly disease in dairy cattle [1]. Various bacteria including contagious and environmental bacterial pathogens, such as Staphylococcus aureus, Streptococcus uberis, and Escherichia coli, cause mastitis [2, 3]. The disease causes considerable economic losses due to decreases in the quality and quantity of milk production, increase in the cost of treatment and veterinary services, and early culling [1, 4]. In addition to therapeutic, prophylactic, and management strategies, one promising approach to reduce mastitis is the selection of animals that are resistant to mastitis and the incorporation of this trait into herds. Although genetic variability for mastitis resistance represents only a small proportion of the total variance, it is not negligible and provides an attractive complementary way to improve mastitis resistance in dairy cattle. Thus, strategies for recognizing and describing these genes are integral to the development of marker-assisted selection, which can increase their frequency and effectiveness, leading to improved ability to combat these pathogens. Resistance/susceptibility to mastitis is a complex trait, and genes involved in the innate immune response have been indicated as strong candidates [1, 5, 6]. The bovine complement system is present in serum and milk and plays an important part in the defense mechanism of the mammary gland against mastitis [7-9]. Complement component 3 (C3) contributes to overall defense, where it is an integral part of the complement system and a key molecule of the three complement reaction pathways: the classical pathway (triggered by antibodies), the lectin pathway (triggered by lectin), and the alternative pathway (triggered directly on pathogen surfaces). The bovine C3 gene is located on chromosome 7, and it contains 40 introns and 41 exons encoding 1661 amino acids (Fig 1). The C3 protein, which is a member of the α2M family, is a 190 kDa glycoprotein essential for eliciting the complement response. It consists of two polypeptide chains (alpha and beta) held together with a single disulfide bridge. An internal thioester in the alpha chain of C3 is cleaved during complement activation. This mediates covalent attachment of the activated C3b to immune complexes and invading microorganisms, thereby opsonizing the target [10].
Fig 1

Shows the protein fragment of C3: The signal peptide and the alpha and beta chains, which consist of the C3a and C3b fragment.

Innate immunity is involved in phagocytosis, inflammation, and immunoregulation processes to destroy infectious microorganisms [11, 12]. Second, the study of transcriptome profiling of Streptococcus uberis-induced mastitis reveals fundamental differences in immune gene expression of the mammary gland and the primary cell culture model. For example, the C3 gene is upregulated by 2.36-fold compared with non-infected control groups [6]. Third, Affymetrix DNA microarrays showed that the mRNA abundances of the C3 gene were strongly and significantly increased (3.8-fold) in mammary epithelial cells (MECs) stimulated by E. coli [13]. Furthermore, complement hemolytic activity and C3 concentration in milk are higher in mammary gland with mastitis than in healthy mammary gland [14, 15]. Finally, some studies also found a significant association between different genotypes of C3 and milk production in sheep (P<0.01) [16] and classical complement pathway and alternative complement pathway activity in porcine (P<0.05) [17]. However, little information is available about the bovine C3 single-nucleotide polymorphisms (SNPs) and their associations with infectious bacterial diseases and complement hemolytic activity. Chinese Holstein Cattle is derived from grading cross breeding and selection between Chinese native cow and purebred Holstein bull introduced in China. The frequency of mastitis in this breed is about 38%–50% [18]. The Luxi Yellow cattle and Bohai Black cattle are two of the representative indigenous bovine (Bos taurus) breeds in China, which have been bred as beef and draft dual-purpose cattle for thousands of years because of their disease resistance and ability to endure unfavorable feeding conditions. The aim of the current study was to investigate the SNPs of the C3 gene and assess their possible associations between SNPs, combined genotypes with SCS, serum C3 concentration, and complement hemolytic activity (ACH50 and CH50) in Chinese Holstein cattle [19].

Materials and methods

Ethical statement

All animal protocols were approved by the Animal Welfare & Ethics Committee of Institute of Animal Sciences, Liaocheng University (No. LC2019-1).

Study animals

The animals used in this study were selected from three common Chinese bovine breeds, including Chinese Holstein (CH; n = 821), Luxi Yellow (LX; n = 106), and Bohai Black (BH; n = 25). Chinese Holstein cattle (4–7 years old and calving numbers one to four) were randomly selected from eight dairy farms in the Jinan and Qingdao Agriculture Development Area, China. Each of the included farms had complete lactation Dairy Herd Improvement (DHI) records. Of the 821 selected individuals, 354 had sufficient serum volume for complement hemolytic activity (CH50 and ACH50) and C3 concentration tests, and samples from these individuals were included in the final analysis. Individuals of the Luxi Yellow and Bohai Black breeds (mean age 14 months) were randomly selected from their original conservation areas. The milk performance parameters (305-day milk yield, somatic cell score (SCS), fat and protein percentage) of Chinese Holstein from 27 sires were provided by the DHI Laboratory of the Dairy Cattle Research Center of Shandong Academy of Agricultural Sciences using a milk composition analyzer (Foss MilkoScan FT 6000, Denmark).

Chemicals and reagents

All chemicals were obtained from Sigma (Saint Louis, USA) except as noted. The EZgene™ Blood Genomic DNA Miniprep Kit, Platinum Taq DNA polymerase, restriction endonucleases, and associated buffers were obtained from TaKaRa Biotechnology Co., Ltd. (Dalian, China). The Bovine Complement 3 ELISA Kit was obtained from BlueGene (Shanghai, China). Oligonucleotide primers were obtained from Sangon Biological Engineering (Shanghai, China). DNA sequencing was performed by TaKaRa (Dalian, China).

DNA extraction

Blood samples were obtained from bovine jugular veins and divided into two treatments. In one tube, 10 ml of blood was mixed with 1.6 ml of the anticoagulant acid-citrate-dextrose (0.48% citric acid, 1.32% citrate sodium, 1.47% dextrose) and subsequently stored at -20°C. A phenol: chloroform protocol modified from the methods of [20] was then used to extract genomic DNA. The other one was used to isolate serum (Chinese Holstein samples), which was stored at -70°C. Genomic DNA was extracted by using the EZgene™ Blood Genomic DNA Miniprep Kit. The quantity and quality of DNA were analyzed spectrophotometrically and diluted to 50 ng/μl. All DNA samples were stored at -20°C for subsequent analysis.

Detection of C3 gene polymorphisms

A total of 21 primer pairs were designed on the basis of the DNA sequence of bovine C3 gene (GenBank accession NO. NC_007305.4) by Primer 5.0 software and synthesized by Sangon Biological Engineering Technology to detect the SNPs in the sequences from the 5′region to the 33th exon (Table 1).
Table 1

The primers to detect the SNPs.

Primer namePrimer sequences 5’→3’AT(°C)SAF (bp)/AR
P1 AAGGTGTCGCAATCAGATAAG 571300
TTCCCTTCACCTAATCTCGTCA g.-1946/g.-547
P2 GCATGCTTAAAAGTAGACTGA 50.4265
CCCAGATTTCTCAATACTGTT g.-376/ g.-102
E1 ACATTGTCCTTGGATAGTGAACT 56.11244
CTAAGTGGCGTCAATCGTGT g.-621/ g.623
I1 TTTCGCGTGGGTGTATGTGG 58.6810
TGGTGACGGTGCTCAGGTAG g.330/ g.1139
E2 AAGAGTCGGACACGATTGACGCCAC 64.6605
AGGACTCTCGGAGCTGGTGCGG g.613/ g.1218
E3,4 TTTCCAAATTCTTGCCTCAT 52.7975
ACAGTAACCGGGTGTCTATCT g.1668/g.2642
I4a GTGCTTGGCGGGTAGTAGGA 52.9602
ACATGCCGCAGTTAAGACG g.3186/ g.3787
I4b GATTTGAACCCAAGCTGACTG 57.9757
CGTACAAGAACCTGCGATGC g.3520/ g.4276
E5/7 GGCAGATGTGGGCAGTTATG 57.91191
GCTGTTCCGTCCACCTGTT g.3646/ g.4836
Gap1 GGGAGGCCATACTGAAACGT 52.9715*
TCTCACCATGAGGTCGAAGG g.5053/ g.5767
E11 TACCCACAGGTGTACGTGAC 54.1533
CACATCTATGCGTGCAAACTA g.5854/ g.6386
E12 ATTGGCAGGCAGATTCTTATC 56.6464
GGACCATGTAGGTGTAGTAGCG g.6666/ g.7129
E12,13 GGGGCTTGGATTTCTCATTG 56.5895
CTGGCCTTTGGCATTAATCAGTGTG g.6518/ g.7412
E13 GCCAAGATCCGCTACTACAC 56.5453
ACAGAGCCAGAGGCACAAGA g.7099/ g.7551
E14 TTCATAAGTAGACGCTTGCAC 52.41873
GGGGAAACAGTAGAAACAAT g.8646/ g.10518
E15 AGAGTCGCTGAGGTTGGTTC 57.9860
CGCCGTGATGTTGGAGTGT g.9006/ g.9865
E20.21 GGTTTGCCATTGCCTTCTCG 61.2877
CTCACTTGCCTCACCCTAATCC g.17433/ g.18309
E22,23 TGTGGCTGTTCGTACACT 49.1533
CCTTTCTAGCTCCGTCTT g.20622/ g.21154
E24 ATCTGTGATAGGAGCGAATA 49.2494
GTGCTGTCCAGGTAGTGC g.21208/ g.21701
E29/31 GGCACGCAAAGACTACGA 54.91777
GGTTCCCATTCCTTACCG g.29105/ g.30881
E30/33 TCTCAGTGCCTCTACCAAT 54.71295
TCAAGACCACGTTGCTAAT g.30195/ g.31453

Note; *When we detect the gap of 63 bp in the NCBI record, we found the Chinese Holstein cows have the 114 bp in the location of the gap by the method of sequencing 15 different dairy cattle farms, so the real length is 766 bp. AT = Annealing temperature.

Note; *When we detect the gap of 63 bp in the NCBI record, we found the Chinese Holstein cows have the 114 bp in the location of the gap by the method of sequencing 15 different dairy cattle farms, so the real length is 766 bp. AT = Annealing temperature. Polymerase chain reaction (PCR) was carried out in a 25 μl reaction mixture containing 50 ng of template DNA, 10 μmol/l of each primer 0.5 μl, 10× buffer 2.5 μl, 50 mmol/l of Mg2+ 0.8 μl, 10 μmol/l of dNTP 0.5 μl, and 5U/μl of Taq DNA polymerase 0.4 μl. After an initial denaturation at 94°C for 5 min, the PCR amplification was performed in 35 cycles using the following parameters: denaturation at 94°C for 30 s, annealing at Tm °C (Table 1) for 30 s, and elongation at 72°C for 30 s. The reaction was continued for a final extension at 72°C for 7 min. The PCR products were evaluated using 1% agarose gel electrophoresis by staining with ethidium bromide. Three new SNPs were found using the DNA pool sequencing method. The SNP (g.56T>C) in the exon I region of the C3 gene was genotyped by PCR-RFLP method with Sty I, and the SNPs (g.-1293C>G and g.7017C>T) in the 5′ region and the exon XII were genotyped by employing created restriction site PCR (CRS-PCR) with primer Ep and Eex12 containing a nucleotide mismatch, respectively, which enable the use of restriction enzymes for discriminating sequence variations [7]. In brief, the third base C is replaced by G from the 3′ end of primer Ep, and the 11th base C is replaced by A from the 5′ end of primer Eex12, which both create a new Hinf Ⅰ restriction site (G/ANTC) (see Table 2). Restriction enzyme selections and fragment sizes are given in Table 2. The detection results of allelic variation at the SNP sites were based on the electrophoretic pattern of the restriction enzyme-treated PCR products.
Table 2

PCR primers and PCR–RFLP tests for genotyping SNPs detected in the bovine C3 gene.

SNP/locationPrimer namePrimer sequences5’→3’SAF (bp)/AREnzyme NameGenotype: RES (bp)
g.-1293C>G 5’regionEpF:TTTGGACGAAGTGCCCTTAAR:GAGAGCTTCCTTGTTCTTGGAG439 (-1646/-1208)Hinf ІCC:439CG:439,416,23GG:416,23
g.56T>C Exon1Eex1F:AAAGGCAGCCTCCAACAACCR: GCTAAGTGGCGTCAATCGTGT651 (-27/623)StyTT:509,142TC:651,509,142CC:651
g.7017C>T Exon12Eex12F:TAACTACCTGAACCTCTCTGTGCR: GGACCATGTAGGTGTAGTAGCG125 (7005/7129)Hinf ІCC:75,50CT:75,50,40,10TT:75,40,10

Abbreviation: SAF = Size of Amplification fragment; AR = Amplification region, RES = size of fragments at the indicated allele after digestion of the PCR product using the respective restriction enzyme; SNP = single nucleotide polymorphism; Underlined nucleotide marks nucleotide mismatches enabling the creation of a restriction enzymes site for discriminating sequence variations.

Abbreviation: SAF = Size of Amplification fragment; AR = Amplification region, RES = size of fragments at the indicated allele after digestion of the PCR product using the respective restriction enzyme; SNP = single nucleotide polymorphism; Underlined nucleotide marks nucleotide mismatches enabling the creation of a restriction enzymes site for discriminating sequence variations. In Table 2, SAF means the size of amplification fragment, AR means amplification region, RES indicates the size of fragments at the indicated allele after digestion of the PCR product using the respective restriction enzyme, and SNP means single-nucleotide polymorphism; underlined nucleotides indicate mismatches between sequences, enabling the creation of a discrimination site for restriction enzymes.

Nucleotide sequencing

The PCR products that showed variable patterns in electrophoresis were sequenced directly from two different directions using the ABI PRISM 3730 DNA analyzer (Applied Biosystems, USA) in accordance with the manufacturer’s instructions. The results were sequenced using the DNASTAR 5.0 package (DNASTAR, Inc., USA).

Classical complement pathway hemolytic titer (CH50) assay

We examined the hemolytic complement activity in 354 individual cattle to assess the in vitro capacity of the complement system in order to evaluate the role of the complement system in host resistance. We followed the established methods of [7, 9, 21] using sensitized rabbit red blood cells (RRBCs) instead of sensitized sheep red blood cells as target cells for measuring the CH50 of bovine. To examine the CH50 of bovine serum, 354 sera from each dairy cattle were diluted with GVB2+ at a ratio of 1:75. Different volumes of the diluted sera ranging from 0.4 ml to 1.0 ml were dispensed into 2.0 ml test tubes, and the total volume reached up to 1.3 ml with GVB2+. For each tube, 0.2 ml of sensitized RRBC suspension (5×108 cells/ml) was added. Hemolysis control (100%) and a cell blank control were included. The tubes were incubated at 37°C for 60 min with occasional shaking and centrifuged at 1000 g for 5 min. The absorbance of the supernatants at 414 nm (OD414) was spectrophotometrically measured [22]. The OD414 values, including those of the 100% hemolysis control, were standardized by subtracting the blank absorbance from all samples. Established methods were used to calculate the CH50 values (units/ml) [23, 24].

Alternative complement pathway hemolytic titer (ACH50) assay

ACH50 assay was performed in accordance with the method of [7]. In general, the levels of complement are expressed in ACH50 titers, which are defined as the reciprocal of the serum dilution causing 50% hemolysis of unsensitized RRBCs. For most experiments, target erythrocytes were drawn from the same giant New Zealand male rabbit and washed three times with EGTA-Mg-GVB. Two buffers were used in the ACH50 activity assay: EGTA-Mg-GVB (pH 7.3, 10 mM EGTA, 4 mM Mg2+) with GVB (5 mM sodium barbiturate, 149 mM NaCl, and 0.1% gelatin) and EDTA-GVB (pH 7.3, 10 mM EDTA, 5 mM sodium barbiturate, 149 mM NaCl, and 0.1% gelatin).

Measurement of C3 protein level in serum

C3 serum concentration in 354 Chinese Holstein cows was measured using the Bovine Complement 3 ELISA Kit (Blue Gene Biotechnology Co., Ltd., Shanghai, China) in accordance with the manufacturer’s instructions. The kit contains a 96-well test plate, standards of known C3 concentrations, wash buffers, a monoclonal anti-C3, a C3-HRP conjugate, and a substrate solution. The serum samples from the Chinese Holstein cattle and standards of known C3 concentrations were loaded into the appropriate well on the antibody-pre-coated microtiter plate; 100 μl of each serum sample or standard per well and 50 μl of the diluted C3-HRP conjugate were added to each well. The plates were covered and incubated for 1 h at 37°C after the solutions were mixed. The wells were washed, and 50 μl of the substrate for the enzyme was added to each well. After incubation at 25°C for 15 min, the wells were washed three times to remove unbound substrates. For each well, 50 μl of Stop Solution was added. Thereafter, the well was mixed properly. The optical density (OD) at 450 nm was measured within 30 min using an ELISA microplate reader. The calibration curve was constructed with OD values, which corresponded to each of the different standard concentrations. This standard curve allowed OD values to be converted to C3 concentrations, expressed in mg/l.

Serum antibacterial activity of different haplotypic combinations

Two of the most common mastitis-causing pathogens Staphylococcus aureus ATCC29213 and Escherichia coli ATCC35218 were purchased from the China Institute of Veterinary Drug Control. These pathogens were incubated in Luria–Bertani (LB) broth or mannitol salt medium and allowed to reach a logarithmic growth phase before bacteria were harvested by centrifugation at 5000 g for 20 min at 4°C. Bacterial pellets were then resuspended in sterilized PBS at a density of 105 CFU/ml and used for further analysis. Results from the haplotypic combination analysis were used to select 12 serum samples from mastitis-resistant individuals (CCC/GCC, H1H5) and 18 samples from mastitis-susceptible individuals (CCC/GTT, H1H8) for examination of antibacterial activity. Mixtures containing 100 μl of individual sera from the mastitis-resistant (CCC/GCC) or mastitis-susceptible samples (CCC/GTT) and an equal volume of E. coli suspended in LB with 105 CFU/ml or S. aureus suspended in mannitol salt agar with 105 CFU/ml were preincubated at 37°C for 12 h. About 30 μl of these mixtures was plated with eosin methylene blue agar for E. coli or mannitol salt agar plate for S. aureus, 6 plates each. Plates were incubated for 24 h at 37°C before colonies in each plate were counted. For the control, the same procedure was followed, but resistant sera were replaced by LB for E. coli or mannitol salt agar for S. aureus. The survival of bacteria was expressed as percent survival relative to the number of cells incubated with LB or mannitol salt agar (100% control). Each sample was tested separately three times [7, 25]. For determination of antibacterial activity in the presence of C3, inhibition experiments were carried out with CTC/GTT serum samples that had been pretreated at 56°C for 30 min, with 10 mM EDTA or with rat anti-bovine C3 (25 μl diluted 10−3) [25]. EDTA or antiserum was added to the individual serum samples for 30 min prior to the addition of E. coli and S. aureus.

Fluorescence quantitative real-time PCR (RT-PCR)

Total RNA was isolated from heart, liver, spleen, lung, kidney, and mammary tissues from six Chinese Holstein cattle (three healthy samples and three diseased samples with clinical mastitis) using TRIzol reagent (Bioteke, Beijing, China) in accordance with the manufacturer’s instructions. cDNA was synthesized with the transcriptor first-strand cDNA synthesis kit (TaKaRa, Dalian, China). RT-PCR analysis was performed using a 20 μl mixture containing 50 ng of cDNA, 0.4 μM of sense and antisense primers, 6.8 μl of dH2O, 10.0 μl of SYBR® Premix Ex Taq™ (2×), and 0.4 μl of ROX Reference Dye (50×) (TaKaRa, Dalian, China). To normalize differences in the amount of total cDNA added to each reaction, the reaction mixture was denatured for 30 s at 95°C and incubated for 40 cycles (denaturing for 5 s at 95°C, annealing for 31 s at 60°C). The primers used in the experiment based on C3 (accession NO. NM_001040469.2) were as follows: F: GAGATTCTGGCCGTGAGCTTG, R: GATCGCTCGGATCTCCACTTG. The PCR was monitored by the ABI PRISM 7000HT Fast Real-Time PCR system. The relative quantification of the C3 gene expression was calculated using the standard curve-based method for relative RT-PCR.

Statistical analysis

The distribution frequency of SCS is usually skewness [8], so we calculated the SCS (cells/μl)-based parameter SCS using the following equation: SCS = log2 (SCS/100) + 3 [26]. Indirect methods of estimation are commonly used. Milk SCS can be employed for selection of mastitis resistance in cattle breeding instead of a direct index of the mastitis phenotype (Interbull: http://www-interbull.slu.se/national_ges_info2/framesida-ges.htm). This indirect index correlates genetically with the occurrence of clinical mastitis (r = 0.7) [26]. TFPGA software was used for genetic analysis, including calculation of both genotypic and allelic frequencies for each SNP, to test for the Hardy–Weinberg equilibrium (χ2) in genotype distributions across breeds and to determine values for polymorphism information content (PIC), heterozygosities (He), and effective number of alleles (Ne) [27]. SHEsis software was employed to conduct haplotype analysis and linkage disequilibrium analysis [28]. Correlation analyses between the three SNPs (single or combined) of the C3 gene and milk traits, the hemolytic activity, and the concentration in Chinese Holstein were analyzed following the general least-square model: where Y = the observed value of each milk trait or serum level trait; μ = overall mean; G = fixed effect of genotype or combined genotype; YS = fixed effect of season; H = fixed effect of farm; P = fixed effect of parity; FS = random effect of sire; e = random error. The antibacterial activity analyses were performed using SPSS Statistics 17.0 software. The data were subjected to Student’s independent samples t-test to determine the differences between the means of the different groups. Values of P<0.05 were considered significant. Multiple comparisons were performed by Duncan’s multiple range test [29].

Results

SNPs of the C3 gene

Compared with the sequence of the bovine C3 gene (GenBank accession NO. NC_007305.4), three new SNPs (g.-1293C>G, g.56T>C, g.7017C>T) were detected in all three tested breeds (Fig 2). One SNP (g.-1293C>G) of the C3 gene was located in the 5′-flanking regions, and the two other SNPs (g.56T>C, g.7017C>T) in exon I and exon XII, which showed one non-synonymous mutation ATG (Met)>ACG (Thr) (at position 19th aa of signal peptide) and one synonymous mutation CAC (His)>CAT (His) (at position 455th aa), respectively. Three new SNPs were submitted to the National Center for Biotechnology Information (NCBI) database (ss289377982, ss289377985, ss289377986). The SNPs such as C>T(rs43501920), A>G (rs43501919), and C>T(rs43501924) of the bovine C3 gene, which had been deposited on the BLASTN program of the NCBI, were not found in our test cattle. We hypothesized that the differences of the bovine population may cause differences in the SNP loci.
Fig 2

Shows the 5′ region and the exons of the C3 gene in the vertical line and the three new SNPs that we found by sequencing.

TESS (http://www.cbil.upenn.edu/cgi-bin/tess/tess) and Signal Scan (http://www-bimas.cit.nih.gov/molbio/signal/) were used to confirm the presence of the TATA box and binding sequence motifs by screening the 2 kb 5′-flanking region upstream of the C3 gene. We found that the loci of g.-1293C>G may be involved in the formation of the GC-rich stem-loop structure. This structure participates in the formation of termination mechanism independent of ρ factor of the prokaryotic terminator.

PCR-RFLP and allele frequencies

The three primers, the respective amplified sizes of fragment, and annealing temperatures for the novel SNPs are shown in Table 2. Digestion of the PCR product by Hinf I (containing the C3 g.-1293C>G locus) generated fragments with lengths of 416 and 23 bp for genotype GG; 439, 416, and 23 bp for genotype CG; and 439 bp for genotype CC. Digestion with Sty I (containing the C3 g.56T>C locus) generated fragments of 651 bp for genotype CC; 651, 509, and 142 bp for genotype CT; and 509 and 142 bp for genotype TT owing to a nucleotide substitution. Digestion of the PCR fragment by Hinf I (containing C3 g.7017C>T locus) produced two bands (75 and 50 bp), four bands (75, 50, 40, and 10 bp), and three bands (75, 40, and 10 bp) for the CC, CT, and TT genotypes, respectively. The 23 and 10 bp fragments were not noticeable in the gel due to their small size (Fig 3).
Fig 3

PCR-RFLP detection results of the three new SNPs (g.-1293C>G, g.56T>C, g.7017C>T) in bovine C3 gene.

The allele and genotype frequencies of the three SNPs in bovine C3 gene are shown in Table 3. The alleles C, T, and C were the dominant alleles at positions g.-1293C>G, g.56T>C, and g.7017C>T, respectively, in the three breeds. The frequency of alleles C, T, and C varied from 0.76 to 0.8821 at g.-1293C>G, 0.6937 to 0.8585 at g.56T>C, and 0.80 to 0.8289 at g.7017C>T in Chinese Holstein, Luxi Yellow, and Bohai Black breeds, respectively. The homozygote CC genotype at position -1293 was the dominant genotype in Chinese Holstein (0.6991), Luxi Yellow (0.8019), and Bohai Black (0.56) breeds. The heterozygous TC at position 56 was the most common genotype in Chinese Holstein (0.4713), while homozygote TT was the most common genotype in Luxi Yellow (0.717) and Bohai Black (0.64) breeds. At the g.7017C>T locus, the homozygote CC genotype was the dominant genotype in Chinese Holstein (0.6955), Luxi Yellow (0.6132), and Bohai Black (0.60) breeds.
Table 3

Genotypic distribution and allelic frequencies of 3 SNPs of the bovine C3 gene of three breeds.

Loci/ Sample sizeGenotypic frequenciesAllelic frequencies
g. -1293C>GCCCGGGCG
CH/8210.69910.27160.02920.8350.165
57422324
LYC/1060.80190.16040.03770.88210.1179
85174
BH/250.560.400.040.760.24
14101
g. 56T>CTTTCCCTC
CH/8210.45790.47130.07080.69370.3063
37638758
LYC/1060.7170.28300.85850.1415
76300
BH/250.640.3600.820.18
1690
g. 7017C>TCCCTTTCT
CH/8210.69550.26670.03780.82890.1711
57121931
LYC/1060.61320.37740.00940.80190.1981
65401
BH/250.600.4000.800.20
15100

Note: “CH” means Chinese Holstein breed, “LYC” means Luxi Yellow breed,“BH” means Bohai Black breed.

Note: “CH” means Chinese Holstein breed, “LYC” means Luxi Yellow breed,“BH” means Bohai Black breed. The genetic index was evaluated in the three breeds. The value of χ2 test, He, Ne, PIC, and Shannon’s information index are presented in Table 4. The result of the χ2 test indicated that only position g.-1293C>G did not meet the Hardy–Weinberg equilibrium (P<0.05) in Luxi Yellow breed, while SNPs g.56T>C and g.7017C>T in all three breeds all met the Hardy–Weinberg equilibrium (P>0.05).
Table 4

χ2 tests, heterozygosities (He), effective number of alleles (Ne) and polymorphism information contents (PIC) of C3 gene of three breeds.

LociBreed/Sampleχ2PICHeNeHardy-Weinberg Equilibrium
g. -1293C>GCH/8210.17180.23760.27561.3805P > 0.05
LYC/1065.56320.18640.2081.2627P < 0.05
BH/250.23280.29830.36481.5743P > 0.05
g. 56T>CCH/8212.19750.32890.41491.7092P > 0.05
LYC/1062.88010.21350.2431.3209P > 0.05
BH/251.20460.25160.29521.4188P > 0.05
g. 7017C>TCH/8212.9290.24350.28371.396P > 0.05
LYC/1063.73350.26730.31771.4657P > 0.05
BH/251.56250.26880.321.4706P > 0.05

Abbreviation: CH = Chinese Holstein breed; LYC = Luxi Yellow breed; BB = Bohai Black breed; P>0.05 means equilibrium and P<0.05 means disequilibrium.

Abbreviation: CH = Chinese Holstein breed; LYC = Luxi Yellow breed; BB = Bohai Black breed; P>0.05 means equilibrium and P<0.05 means disequilibrium. The linkage disequilibrium estimation indicated that the three SNPs were unlinked in the 821 Chinese Holstein cattle (D’<0.75, r2<0.33) (Table 5).
Table 5

Analysis of pairwise linkage disequilibrium in C3 gene.

g.-1293C>Gg.56T>Cg.7017C>T
g.-1293C>G-0.0380.548
g.56T>C0-0.123
g.7017C>T0.0120.001-

Note: D’ is above the diagonal for SNPs and r2 is below the diagonal.

Note: D’ is above the diagonal for SNPs and r2 is below the diagonal.

Relationships between SNPs, combined genotypes of C3 gene, and Chinese Holstein cow milk production traits

Table 6 summarizes the effects on milk production traits (rates of fat and protein and milk yield at 305-days) and SCSs. Polymorphism at g.56T>C was strongly correlated with SCS (P<0.05). Cattle that showed the homozygous genotype CC, rather than TC or TT, at position 56 also showed significantly lower SCS (P<0.05). Polymorphism at g.-1293C>G was related to protein rate for studied Chinese Holstein cattle (P<0.05). The homozygous genotype GG at position -1293 had significantly higher protein content than those with genotypes of CC and CG (P<0.05). However, no significant correlation between g.-1293C>G/g.7017C>T polymorphism and SCS/milk traits was found in 821 Chinese Holstein cattle (P>0.05) (Table 6).
Table 6

Least squares mean (LSM) and standard errors (SE) for SCS, fat, protein rate and milk yield of different C3 genotypes in 821 Chinese Holstein.

SNPGenotype/SamplesSomatic cell scoreProtein Content (%)Fat Content (%)305 d milk yield (kg)
g.-1293C>GCC/5744.12±0.263.00±0.06b3.51±0.195849.16±316.52
CG/2234.12±0.282.92±0.06b3.37±0.205667.83±340.01
GG/244.21±0.473.02±0.11a3.38±0.346216.51±573.31
g. 56T>C 791TT/3764. 17±0.23a2.94±0.073.36±0.205892.04±344.77
TC/3874. 06±0.24a2.96±0.073.39±0.215831.76±356.72
CC/583.65±0.33b3.03±0.093.31±0.276009.70±454.95
g.7017C/TCC/5714.06±0.232.97±0.063.30±0.195965.12±329.57
CT/2194.01±0.252.90±0.073.32±0.215938.00±360.40
TT/314.42±0.383.07±0.103.62±0.315830.40±513.74

Note: Mean values with the different small letters within the same row and loci differ at P<0.05.

Note: Mean values with the different small letters within the same row and loci differ at P<0.05. The polymorphism at g.56T>C and g.7017C>T was significantly correlated with serum ACH50 values in 354 Chinese Holstein cows (P<0.01) (Table 7). The homozygous genotype CC at position 56 had significantly higher ACH50 than the genotypes of TC and TT (P<0.01), while the homozygous genotype CC at position 7017 had significantly lower ACH50 than genotypes of CT and TT (P<0.01). The correlation between g.-1293C>G polymorphism and ACH50 was insignificant for the 354 Chinese Holstein cattle (P>0.05).
Table 7

Least squares mean (LSM) ± standard errors (SE) of various milk production traits in relation to different C3 genotypes among 354 Chinese Holstein cows.

SNP LocusGenotype /samplesC3 level (mg/ml)CH50 (U/ml)ACH50 (U/ml)
g.-1293C>GCC/2632.50±0.6768.46±4.1129.50±1.25
CG/862.98±0.7364.61±4.5128.34±1.37
GG/52.84±1.9262.35±11.8428.94±3.60
g. 56T>CTT/1842.77±0.6667.65±4.0929.42±1.2B
TC/1512.38±0.7266.40±4.4528.33±1.34B
CC/192.44±1.1464.60±7.0332.98±2.11A
g.7017C>TCC/2362.45±0.6668.63±4.0728.25±1.23B
CT/953.23±0.7462.84±4.5331.25±1.37A
TT/232.10±1.0673.60±6.5229.82±1.96A

Note: Mean values superscripted with “A” are very significantly higher than those superscripted with “B”, P<0.01 within the same row and loci.

Note: Mean values superscripted with “A” are very significantly higher than those superscripted with “B”, P<0.01 within the same row and loci. The C3 SNPs (g.-1293C>G, g.56T>C, and g.7017C>T) were used for haplotype reconstruction, including H1: CCC, H2: CCT, H3: CTC, H4: CTT, H5: GCC, H6: GCT, H7: GTC, and H8: GTT. The estimated frequencies were 0.208, 0.040, 0.476, 0.113, 0.043, 0.002, 0.108, and 0.009 for H1–H8, respectively. Among them, H6 was the least common, while H3 was the most common. Although 27 combined haplotypes were possible across the three SNPs, only 21 combinations were observed in the studied Chinese Holstein individuals. Six combined genotypes, H1H6(3), H2H2(2), H2H8(2), H4H8(3), H5H8(1), and H7H8 (2), were not included in the association analysis due to the small sample sizes (<4). Statistical results showed that the fat rate, SCS, and protein rate in combinations of haplotype (three SNPs) are significantly different (P<0.05) in the 821 tested Chinese Holstein population (Table 7). No significant difference in 305-day milk yield was determined in various haplotype combinations (Table 8). The individuals with haplotype combination of H1H5 presented a lower SCS than those with haplotype combinations of H1H8 and H4H4 (P<0.05). The individuals with haplotype combinations of H1H1 and H4H4 showed significantly higher protein rate than those with haplotype combinations of H1H4, H1H8, H3H4, and H3H7 (P<0.05). The individuals with haplotype combination of H1H1 had significantly higher fat rate than those with haplotype combination of H1H8 (P<0.05).
Table 8

Least squares mean (LSM) and standard error (SE) for SCC、fat、protein and milk yield of different C3 haplotype combinations in 821 Chinese Holstein.

Haplotype combination/SamplesSomatic cell scoreProtein Content (%)Fat Content (%)305 d milk yield (kg)
H1H1/273.96±0.403.10±0.09a3.45±0.29a6039.00±501.34
H1H2/154.18±0.633.02±0.143.43±0.445288.94±733.87
H1H3/1714.06±0.262.97±0.063.36±0.195803.80±322.12
H1H4/623.96±0.312.89±0.07b3.40±0.235711.16±381.00
H1H5/122.49±0.54b2.85±0.132.86±0.395866.80±669.71
H1H7/894.23±0.292.93±0.073.32±0.215514.39±363.30
H1H8/184.63±0.45a2.83±0.11b2.71±0.32b5643.32±554.15
H2H4/74.49±0.642.88±0.153.43±0.466597.67±787.14
H3H3/1873.97±0.252.95±0.063.13±0.185911.60±315.66
H3H4/844.02±0.302.88±0.07b3.26±0.225839.48±376.34
H3H7/833.97±0.302.83±0.07b3.19±0.225636.13±372.92
H3H8/203.35±0.512.92±0.122.73±0.375828.42±614.93
H4H4/174.52±0.49a3.18±0.12a3.49±0.365076.86±607.42
H5H7/73.79±0.672.87±0.163.20±0.496310.23±825.53
H7H7/113.86±0.593.04±0.142.86±0.435847.63±727.69

Abbreviation: H1 = CCC, H2 = CCT, H3 = CTC, H4 = CTT, H5 = GCC, H6 = GCT, H7 = GTC and H8 = GTT. Means with the different small letters within the same row differ at P < 0.05 and means without any superscript do not differ statistically (P > 0.05).

Abbreviation: H1 = CCC, H2 = CCT, H3 = CTC, H4 = CTT, H5 = GCC, H6 = GCT, H7 = GTC and H8 = GTT. Means with the different small letters within the same row differ at P < 0.05 and means without any superscript do not differ statistically (P > 0.05). No significant difference in C3 concentration and CH50 305-day milk yield was observed in various haplotype combinations in 354 Chinese Holstein cows (Table 9). However, the individuals with haplotype combination of H1H2 showed higher ACH50 value than those with haplotype combinations of H1H3 (P = 0.0008) and H3H7 (P = 0.001) in 354 Chinese Holstein cows.
Table 9

Least squares mean (LSM) + standard error (SE) of C3 concentration, ACH50 and CH50 values in different haplotypic combinations among 354 Chinese Holstein cows.

Haplotype combination /NumbersC3 Concentration (μg/ml)CH50 (U/ml)ACH50 (U/ml)
H1H1/112.75±1.3971.09±8.5729.64±2.54
H1H2/61.92±1.7958.07±11.0141.44±3.26A
H1H3/681.66±0.8269.17±4.9927.08±1.48B
H1H4/333.49±0.9964.74±6.0529.54±1.79
H1H7/322.36±0.9865.44±6.0228.52±1.78
H1H8/51.53±1.9241.47±11.7530.68±3.48
H2H4/71.72±1.7176.83±10.5131.18±3.12
H3H3/822.17±0.7870.19±4.7929.16±1.42
H3H4/443.14±0.8766.08±5.3431.39±1.58
H3H7/373.50±0.8168.34±5.5927.26±1.65B
H3H8/62.88±1.7754.78±10.8429.91±3.21
H4H4/121.60±1.3871.67±8.4628.82±2.51
H5H7/42.91±2.1467.70±13.1229.19±3.89

Abbreviations: H1 = CCC, H2 = CCT, H3 = CTC, H4 = CTT, H5 = GCC, H6 = GCT, H7 = GTC and H8 = GTT. Note: Mean values superscripted with “A” are very significantly higher than those superscripted with “B”, P<0.01 within the same row and loci.

Abbreviations: H1 = CCC, H2 = CCT, H3 = CTC, H4 = CTT, H5 = GCC, H6 = GCT, H7 = GTC and H8 = GTT. Note: Mean values superscripted with “A” are very significantly higher than those superscripted with “B”, P<0.01 within the same row and loci.

C3 gene expression

The C3 gene expression levels differed across tissues between healthy and mastitic cattle (Fig 4). Quantitative data indicate that the spleen, heart, and liver tissues had higher C3 expression than the mammary tissues in healthy Chinese Holstein cows (normal group). However, the C3 expression levels were significantly increased in lung and mammary tissues in mastitic cows (abnormal group) compared with those in healthy animals (P<0.05), while the C3 expression levels were significantly decreased in heart, spleen, liver, and kidney tissues in mastitic cows (abnormal group) compared with those in healthy animals (P<0.01).
Fig 4

C3 expression in different tissues of healthy cow samples and diseased samples.

C3 antibacterial activity

Genetically resistant cows (H1H5) had serum with noticeably higher antibacterial activity against S. aureus and E. coli (Fig 4) in vitro than genetically susceptible H1H8 cows (P<0.05). Resistant serum (H1H5) that was preincubated with EDTA, heated at 56°C for 30 min, or treated with C3 antibody lost antibacterial activity against both tested strains (Fig 5).
Fig 5

Serum antibacterial activity of resistant and susceptible cows and neutralization of antibacterial activity from resistant subjects by specific inhibition of C3.

The differences in Log (CFU/ml) between resistant serum and others were highly significant (P<0.001). Data are means ± standard deviation.

Serum antibacterial activity of resistant and susceptible cows and neutralization of antibacterial activity from resistant subjects by specific inhibition of C3.

The differences in Log (CFU/ml) between resistant serum and others were highly significant (P<0.001). Data are means ± standard deviation.

Discussion

Complement, one of the essential effective systems of innate immunity, is present in lower animals such as fish and higher animals such as humans and bovines [30]. The complement system plays a crucial role in innate defense against pathogens and serves as a functional bridge with adaptive immunity to allow integrated host defense [31]. It is a potential therapeutic target for improved general immune response in many species. In the current study, we scanned most exons of the C3 sequence to study the associations between polymorphisms in the C3 gene with the productive traits and immune response traits [18]. The SNP (g.56T>C) in exon I showed one non-synonymous mutation ATG (Met)>ACG (Thr). The loci are at position 19th aa of the signal peptide, which is the C-terminal near the side of action of the signal peptidase. The C-terminal plays an essential role in combining the C3 protein with signal recognition particle, indicating that the region affects the C3 secretion [32]. Twenty-one primer pairs were designed based on DNA sequence of the bovine C3 gene (GenBank accession NO. NC_007305.4) and synthesized to find the SNPs (Table 1). More than 18,000 bp had been detected, only three SNPs have been found in 952 individuals of Chinese Holstein, Luxi Yellow, and Bohai Black breeds. Thus, the gene may be relatively conservative. However, the three breeds did not show all three different genotypes: the Luxi Yellow and Bohai Black cattle with the SNP (g.56T>C) only showed the TT and TC genotypes, while Bohai Black cattle with the SNP (g.7017C>T) only showed the CC and CT genotypes (Table 3). The χ2 test results showed that the three SNPs all accord with the Hardy–Weinberg disequilibrium (P>0.05), except for the Luxi Yellow cattle with the SNP (g.-1293C>G) (Table 4). This finding implies that the three SNPs become stable after long-term artificial selection in the chosen samples. The SNP (g.-1293C>G) is significantly associated with the protein content (Table 6), and the protein content of cows with g.-1293C>G-GG genotype is considerably higher than that of cows with g.-1293C>G-CC and -CG genotypes (P<0.05). The SCS of cows with g.56T>C-CC genotype was significantly lower than that of cows with g.56T>C-TC and -TT genotypes (P<0.05). However, the ACH50 value of cows with g.56T>C-CC genotype was significantly higher than that of cows with g.56T>C-TC and -TT genotypes (P<0.01). The allelic frequencies of G and C of g.-1293C>G and g.56T>C are 16.5% and 29.38%, respectively (Table 3). The results confirmed the importance of the two SNPs, which are better for animals to resist pathogens. The study wanted to determine why the value of ACH50 was significantly associated with cows with the SNP (g.7017C>T) (P<0.01) (Table 3) and cows with CC have significantly lower ACH50 than those with TT and CT. A previous study [33] found that rare silent mutation can affect protein function in some cellular environments. It may be due to the T allele leading to some three-dimensional structure change of the C3 beta chain and involving the process or the other protein to combine it. In this study, individuals with the haplotype combination of H1H1 (CCC/CCC) showed higher protein and fat contents (P<0.05) than those with haplotype combinations of H1H8 (CCC/GTT) (P<0.05). Given that individuals with haplotype combination of H1H5 (CCC/GCC) showed significantly lower SCSs and the lowest C3 concentration in serum than individuals with haplotype combinations of H1H8 (CCC/GTT) (P = 0.0007) and H4H4 (CTT/CTT) (P = 0.0021), we can conclude that H1H8 (CCC/GTT) should be abandoned. Cattle with H1H1 (CCC/CCC) and H1H5 (CCC/GCC) haplotype combinations can be selected for breeding to obtain low SCS. Cattle with H1H1 (CCC/CCC) and H1H5 (CCC/GCC) haplotype combinations can be selected for breeding to obtain low SCS. Cows with haplotype combination of H2H4 (CCT/CTT) had a higher value of CH50 and 305-day milk yield than other cows (P>0.05). The individuals with haplotype combination of H1H2 (CCC/CCT) had significantly higher ACH50 than those with haplotype combinations of H1H3 (CCC/CTC) (P = 0.0008) and H3H7 (CTC/GTC) (P = 0.001). Thus, cows having haplotype combinations of H2H4 and H1H2 can be used for breeding to become more resistant to pathogens. A previous study [34] reported the crystal structure of the C3 convertase formed by C3b and the protease fragment Bb, which was stabilized by the bacterial immune-evasion protein SCIN (Staphylococcal complement inhibitor). Thus, the SCIN from S. aureus can obstruct the activation of C3 protein and can affect a series of reactions caused by C3 activation [34]. The results of the preliminary test of antibacterial activity of C3 (Fig 5) further verified that cows with the haplotype combination of H1H5 (CCC/GCC) are more resistant than those with H1H8 (CCC/GTT). The bacterial count increased when resistant serum samples with the H1H5 (CCC/GCC) haplotype combination were incubated with EDTA and C3 antibody samples and treated at 56°C for 30 min (Fig 5). This finding indicates that C3 protein plays an indispensable role in the complement system. Mastitis resistance is a complex trait. It depends on a genetic component and physiological and environmental factors, including infectious pressure Intramammary infections with E. coli often result in acute mastitis with severe clinical consequences [3]. Some S. aureus infections may also cause subclinical mastitis with no apparent clinical symptoms (e.g., swelling of the udder, milk flakes, fever) and only intermittent detection of bacteria in milk paired with elevated somatic cell counts. Our findings demonstrate an association between the C3 gene and hemolytic complement activity. Although complement is a complex multigene process, which serves in the defence against many pathogenic agents, this aspect of complement is now better understood, reinforcing the overall importance of C3 as a candidate gene for natural forms of defence against various microorganisms. For humans, homozygous deficiency at the C3 locus is a rare autosomal disease characterized by increased susceptibility to bacteria such as Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae [35, 36] or viral infections [37]. C3 plays a vital role as an opsonin for bacteria during the early years of life and is less critical in adults, in whom protective antibodies and anamnestic responses have developed [38]. Several studies have investigated the association of polymorphisms in the C3 component of the male complement system and the susceptibility of some of its alleles to some diseases. The Human serum complement C3 component is the core of the complement system. Several receptor sites of the C3 molecule act broadly with pathogens, blood cells, and stromal cells [39, 40], especially the sites that bind to the type I receptor of the erythrocyte complement (CR1, CD35) and the complement type III receptor of the monocytes and macrophages (CR3, CD11b/CD18) [36]. Thus, C3 mediates the adhesion of pathogens, killing and clearing the immune complex in vivo as a bridge [37]. The study indicates that the C3 gene plays a role in resistance to bacterial infection and can be used as a molecular marker for complement activity and traits related to milk production. This study is the first to describe the association between polymorphisms in the bovine C3 gene and milk production traits and complement activity, which has never been done before. Our study investigated the bovine C3 as a candidate gene for complement activity and provides valuable information for further research. Therefore, the compound effect of haplotypes and combined genotypes should be analyzed instead of single locus.

Bohai Black cattle.

(TIFF) Click here for additional data file.

Chinese Holstein cattle.

(TIFF) Click here for additional data file.

Luxi Yellow cattle.

(TIFF) Click here for additional data file. (PDF) Click here for additional data file. 6 Oct 2021
PONE-D-21-26730
Complement component 3 haplotypes influence serum complement activity and milk production traits in Chinese Holstein cattle
PLOS ONE Dear Dr. Wang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 20 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Tomoyoshi Komiyama, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels. In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions. 3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 4. Thank you for submitting the above manuscript to PLOS ONE. During our internal evaluation of the manuscript, we found significant text overlap between your submission and the following previously published works. - https://linkinghub.elsevier.com/retrieve/pii/S0163445306002076 - http://www.funpecrp.com.br/gmr/year2011/vol10-1/pdf/gmr1038.pdf - https://pubmed.ncbi.nlm.nih.gov/16831446/ - https://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.7b00882 - https://hal.archives-ouvertes.fr/hal-00902900/file/hal-00902900.pdf - https://pubs.acs.org/doi/abs/10.1021/pr100336e We would like to make you aware that copying extracts from previous publications, especially outside the methods section, word-for-word is unacceptable, even for works which you authored. In addition, the reproduction of text from published reports has implications for the copyright that may apply to the publications. Please revise the manuscript to rephrase the duplicated text, cite your sources, and provide details as to how the current manuscript advances on previous work. Please note that further consideration is dependent on the submission of a manuscript that addresses these concerns about the overlap in text with published work. We will carefully review your manuscript upon resubmission, so please ensure that your revision is thorough. Additional Editor Comments: Dear Authors, The focus of your study was to investigate the SNPs of the C3 gene and assess their possible associations between SNPs, combined genotypes with SCS, serum C3 concentration, and complement hemolytic activity in 952 cattle from three Chinese Holstein cattle species. I have some concerns about the manuscript that you might consider. Three reviews below are from reviewers who have pointed out questions for your manuscript. All reviewers are critical to your manuscript. In particular, reviewer 2 and 3 is critical to your manuscript. However, I have carefully considered your manuscript up until now. I decided to major revision based on the three reviewer’s comments. I think these comments will be very helpful in the revision of your manuscript. It is unclear what this study reveals and what your results provide and what will be helpful for research in the future. If these results become clear, I think your research is important for the future of any researchers who aim to better understand your research. Also, there are some comments from your manuscript. Please use this for reference as well. Tomoyoshi Komiyama, Ph.D [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This work includes interesting findings. The authors have investigated the polymorphisms and their possible implications, with particular investigative focus on their associations with mastitis resistance, serum C3 level, complement hemolytic activity (CH50 and ACH50), and milk production traits, Bacterial counts of serum antibacterial activities were also completed to verify the effect of SNPs on resistance to mastitis pathogens. Comments: There are too many paragraphs in text, some of paragraphs could be merged. Conclusion need to be rewritten. The manuscript requires English polishing. The results of gene expression and antibacterial activity have to be summarized and displayed in abstract. The symbols of significance are missing in Fig 3 and Fig 4. In Fig 3, does the error bar meas SD or SE? In Fig 4, group name should to be consistent with text in line 391. Line 404: ATG(Met)>ACG(Thr). The loci are at position 19th suggest be changed to ATG (Met) > ACG (Thr). The loci are at position 19 th. Line 489-491: suggest to add the reference. Line 509:  Janssen B. J. et al, 2005; Sreis E. et al, 2006 suggest be changed to Janssen et al, 2005; Sreis et al, 2006. Reviewer #2: The article entitled Complement component 3 haplotypes influence serum complement activity and milk production traits in Chinese Holstein cattle is a well written manuscript that depicts an interesting research. However, the file that was presented to me for review did not contain tables mentioned in the manuscript, therefore I was not able to verify the data described in the text. Line 165 – please provide information on what breeds were these cattle? Line 287-8 – this belongs to the introduction. L 397 – 402 - this belongs to the introduction. L 405-407 – please add reference regarding the C-terminal role. It would be good to finish the article with a clear conclusions that would also show possible benefits of the findings. AS it is the second to last paragraph is more of a conclusion than the last paragraph. Reviewer #3: Dear Authors, The authors results showed that complement component 3 haplotypes influence serum complements activity and milk production traits in Chinese Holstein cattle. However, I think that it is necessary to strengthen the reliability of the result by adding as much information as possible for readers. Major comments: 1. I recommend a flow diagram of the number of cattle included and clarify the number of samples you used for each analysis. Then clarify the content of the discussion section. I cannot understand relative with results of each analysis and discussion. 2. The authors should be more clearly stated in the discussion section. 3. I think your research is good, but your sample numbers are not clear enough for most readers to understand. I strongly recommend the authors check and correct their manuscript. 4. I would like you to clearly describe in the discussion how the clarification of this research will be useful in agriculture practice. 5. I would like you to recommend include a photo of the three Chinese Holstein cattle species and describe their characteristics in the Methods section. 6. Also, please specify the relationship between the characteristics of the three Chinese Holstein cattle species and your results. 7. The authors should check the calculation method to your test. 8. Also, please revise some English texts, again. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. 2 Mar 2022 Dear Editor, We are very thankful for the reviews which gave us an opportunity to improve our manuscript. Our manuscript has been revised according to the review’s comments. We hope that after this revision it will achieve the publication requirements of PLoS ONE Journal. Below there are our answers (in blue) for all remarks issued by reviewers. Finally, we restructured the paper to follow PLoS ONE format. The following are our point-to-point responses. Acknowledgement Our deepest gratitude goes to the anonymous reviewer for their careful work and thoughtful suggestions that improved the manuscript substantially. Changfa Wang Ph.D., Professor College of Agronomy, Liaocheng University, No.1 Hunan Road, Dongchangfu District, Liaocheng City, Shandong Province, P. R. China, Zip code: 252059 Reviewer 1: Q: There are too many paragraphs in text, some of paragraphs could be merged. Conclusion need to be rewritten. The manuscript requires English polishing. A: Thanks for your suggestions. We have already polished English and modified manuscript. Q: The results of gene expression and antibacterial activity have to be summarized and displayed in abstract. A: Thanks for your suggestions. We have already modified the manuscript and summarized gene expression and antibacterial activity in abstract. Q: The symbols of significance are missing in Fig 3 and Fig 4. In Fig 3, does the error bar means SD or SE? In Fig 4, group name should to be consistent with text in line 391. A: Thanks for your suggestions. Data are means ± standard deviation in Fig. 3. Additionally, the group name has changed and consistent with text in Fig. 4. Q: Line 404: ATG (Met)>ACG (Thr). The loci are at position 19th suggest be changed to ATG (Met) > ACG (Thr). The loci are at position 19th. A: Thanks for your suggestions. We have already corrected this error. Q: Line 489-491: suggest to add the reference. A: Thanks for your suggestions. We have already added the reference. Q: Line 509: Janssen B. J. et al, 2005; Sreis E. et al, 2006 suggest be changed to Janssen et al, 2005; Sreis et al, 2006. A: Thanks for your suggestions. We have already changed the format. Reviewer 2: Q: Line 165 please provide information on what breeds were these cattle? A: Thanks for your suggestions. The information of breeds on these cattle we provided in introduction part. “The animals used in this study were selected from three common Chinese bovine breeds, including Chinese Holstein (CH; n=821), Luxi Yellow (LX; n=106), and Bohai Black (BH; n=25)” (now line 93-95). Q: Line 287-8 this belongs to the introduction. A: Thanks for your suggestions. We have already moved this part to introduction. Q: L 397-402 this belongs to the introduction. A: Thanks for your suggestions. We have already moved this part to introduction. Q: L 405-407 please add reference regarding the C-terminal role. A: Thanks for your suggestions. We have already added the reference. Q: It would be good to finish the article with a clear conclusion that would also show possible benefits of the findings. AS it is the second to last paragraph is more of a conclusion than the last paragraph. A: Thanks for your suggestions. We have already modified the conclusion and discussion part. Reviewer 3: Q: I recommend a flow diagram of the number of cattle included and clarify the number of samples you used for each analysis. Then clarify the content of the discussion section. I cannot understand relative with results of each analysis and discussion. A: Thanks for your suggestions. We have already modified the discussion section. Q: The authors should be more clearly stated in the discussion section. A: Thanks for your suggestions. We have already modified the discussion section. Q: I think your research is good, but your sample numbers are not clear enough for most readers to understand. I strongly recommend the authors check and correct their manuscript. A: Thanks for your suggestions. We have already polished English and modified manuscript. Q: I would like you to clearly describe in the discussion how the clarification of this research will be useful in agriculture practice. A: Thanks for your suggestions. We have already modified the discussion section. Q: I would like you to recommend include a photo of the three Chinese Holstein cattle species and describe their characteristics in the Methods section. A: Thanks for your suggestions. Chinese Holstein Cattle Luxi Yellow cattle Bohai Black cattle Q: Also, please specify the relationship between the characteristics of the three Chinese Holstein cattle species and your results. A: Thanks for your suggestions. Chinese Holstein Cattle is derived from grading cross breeding and selection between Chinese native cow and purebred Holstein bull introduced in China. The frequency of mastitis in this breed is about 38%–50% [17]. The Luxi Yellow cattle and Bohai Black cattle are two of the representative indigenous bovine (Bos taurus) breeds in China, which have been bred as beef and draft dual-purpose cattle for thousands of years because of their disease resistance and ability to endure unfavorable feeding conditions. Q: The authors should check the calculation method to your test. A: Thanks for your suggestions. We have already checked the calculation method. Q: Also, please revise some English texts, again. A: Thanks for your suggestions. We have already polished English and modified manuscript. Submitted filename: 3.2_Reponse Letter.docx Click here for additional data file. 24 Mar 2022
PONE-D-21-26730R1
Complement component 3 haplotypes influence serum complement activity and milk production traits in Chinese Holstein cattle
PLOS ONE Dear Dr. Wang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.
Please submit your revised manuscript by May 08 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Tomoyoshi Komiyama, Ph.D Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): Dear authors, Thank you for submitting your revised manuscript. I think it is easier to understand than the previous manuscript. However, it received some additional questions from the reviewer. Please answer these questions. Tomoyoshi Komiyama [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: Thera are still some minor changes that can be made to the language. Discussion – it seems that some paragraphs in Discussion contain only the description of results and then a sentence form the authors providing a conclusion or a an attempt to explain these results. I feel that these paragraph could use also referencing to other studies. The last paragraph of the manuscript should have a clear conclusions. Please add such a paragraph, as it is the last paragraph (“For humans, homozygous deficiency at the C3 locus…..”) is still a discussion. The paragraph before is more of a conclusion. A reader would like to know what is your thoughts and summary of the research, potential use – and they would typically look at the last paragraph. Reviewer #3: Thank you for submitting your revised manuscript. The authors revised the sentences according to my comments. Therefore, I have no further questions. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
27 Apr 2022 Reviewer 1: No questions Reviewer 2: Q: Thera are still some minor changes that can be made to the language. A: Thanks for your suggestions. We have already modified the manuscript. Q: The last paragraph of the manuscript should have a clear conclusion. Please add such a paragraph, as it is the last paragraph (“For humans, homozygous deficiency at the C3 locus….”) is still a discussion. The paragraph before is more of a conclusion. A reader would like to know what is your thoughts and summary of the research, potential use – and they would typically look at the last paragraph. A: Thanks for your suggestions. We have already changed the discussion part and added the last paragraph. Reviewer 3: No questions Submitted filename: 4.17_Reponse Letter.docx Click here for additional data file. 12 May 2022 Complement component 3 haplotypes influence serum complement activity and milk production traits in Chinese Holstein cattle PONE-D-21-26730R2 Dear Dr. Wang, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Tomoyoshi Komiyama, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): Dear authors, Thank you for submitting your revised manuscript. I think it was much easier to understand than the original manuscript. I am satisfied with the responses and the edits, I am happy to accept this manuscript. The authors have replied to my remaining questions satisfactorily from three reviewers. Therefore, I have no further comments to make, all of my previous concerns were adequately addressed. This manuscript will be satiating the reader's interest. Tomoyoshi Komiyama Reviewers' comments: 7 Jun 2022 PONE-D-21-26730R2 Complement component 3 haplotypes influence serum complement activity and milk production traits in Chinese Holstein cattle Dear Dr. Wang: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Tomoyoshi Komiyama Academic Editor PLOS ONE
  34 in total

1.  Genetic parameters for clinical mastitis, somatic cell score, production, udder type traits, and milking ease in first lactation Holsteins.

Authors:  R Rupp; D Boichard
Journal:  J Dairy Sci       Date:  1999-10       Impact factor: 4.034

2.  SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci.

Authors:  Yong Yong Shi; Lin He
Journal:  Cell Res       Date:  2005-02       Impact factor: 25.617

Review 3.  Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.

Authors:  Daniel Ricklin; Edimara S Reis; Dimitrios C Mastellos; Piet Gros; John D Lambris
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

Review 4.  Invited review: Mastitis in dairy heifers: nature of the disease, potential impact, prevention, and control.

Authors:  S De Vliegher; L K Fox; S Piepers; S McDougall; H W Barkema
Journal:  J Dairy Sci       Date:  2012-03       Impact factor: 4.034

5.  Complement component 3: characterization and association with mastitis resistance in Egyptian water buffalo and cattle.

Authors:  Nermin El-Halawany; Shawky A Abd-El-Monsif; F M Al-Tohamy Ahmed; Lamees Hegazy; Hamdy Abdel-Shafy; Magdy A Abdel-Latif; Yasser A Ghazi; Christiane Neuhoff; Dessie Salilew-Wondim; Karl Schellander
Journal:  J Genet       Date:  2017-03       Impact factor: 1.166

6.  Three novel single-nucleotide polymorphisms of complement component 4 gene (C4A) in Chinese Holstein cattle and their associations with milk performance traits and CH50.

Authors:  Yue Yang; Qiuling Li; Zhihua Ju; Jinming Huang; Lei Zhou; Rongling Li; Jianbin Li; Fangxiong Shi; Jifeng Zhong; Changfa Wang
Journal:  Vet Immunol Immunopathol       Date:  2011-11-19       Impact factor: 2.046

7.  Desmoid tumors: a 20-year radiotherapy experience.

Authors:  N E Sherman; M Romsdahl; H Evans; G Zagars; M J Oswald
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-07       Impact factor: 7.038

8.  Mannose-binding lectin 1 haplotypes influence serum MBL-A concentration, complement activity, and milk production traits in Chinese Holstein cattle.

Authors:  Jianbo Liu; Zhihua Ju; Qiuling Li; Jinming Huang; Rongling Li; Jiangbin Li; Lijuan Ma; Jifeng Zhong; Changfa Wang
Journal:  Immunogenetics       Date:  2011-06-22       Impact factor: 2.846

Review 9.  Complement in human diseases: Lessons from complement deficiencies.

Authors:  Marina Botto; Michael Kirschfink; Paolo Macor; Matthew C Pickering; Reinhard Würzner; Francesco Tedesco
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

10.  Assessment of the immune capacity of mammary epithelial cells: comparison with mammary tissue after challenge with Escherichia coli.

Authors:  Juliane Günther; Dirk Koczan; Wei Yang; Gerd Nürnberg; Dirk Repsilber; Hans-Joachim Schuberth; Zaneta Park; Nauman Maqbool; Adrian Molenaar; Hans-Martin Seyfert
Journal:  Vet Res       Date:  2009-03-27       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.